Inventor

PALESE PETER

US79 patents

⚠️ This page may combine multiple inventors who share the name “PALESE PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PALESE PETER

SINAI SCHOOL MEDICINE

Recombinant new castle disease virus RNA expression systems and vaccines

Recombinant negative strand RNA virus expression systems and vaccines

Recombinant negative strand RNA virus expression systems and vaccines

Methods and interferon deficient substrates for the propagation of viruses

Helper-free rescue of recombinant negative strand RNA virus

Helper-free rescue of recombinant negative strand RNA viruses

Methods and interferon deficient substrates for the propagation of viruses

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

Methods and interferon deficient substrates for the propagation of viruses

Recombinant newcastle disease virus RNA expression systems and vaccines

Recombinant negative strand RNA virus expression systems and vaccines

Recombinant negative strand rna virus expression-systems

Helper-free rescue of recombinant negative strand RNA virus

Interferon inducing genetically engineered attenuated viruses

Recombinant Newcastle disease virus RNA expression systems and vaccines

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication

Interferon inducing genetically engineered attenuated viruses

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

Chimeric Newcastle disease viruses and uses thereof

ICAHN SCHOOL MED MOUNT SINAI

Influenza virus vaccines and uses thereof

Influenza virus vaccines and uses thereof

Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof

Influenza virus vaccination regimens

Influenza virus vaccines and uses thereof

Chimeric viruses presenting non-native surface proteins and uses thereof

Influenza virus vaccines and uses thereof

Influenza virus hemagglutinin proteins and uses thereof

Anti-influenza B virus neuraminidase antibodies and uses thereof

Antibodies against influenza virus hemagglutinin and uses thereof

Influenza virus vaccines and uses thereof

Antibodies against influenza virus hemagglutinin and uses thereof

Influenza virus vaccines and uses thereof

PALESE PETER

Chimeric Newcastle disease viruses and uses thereof

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

Genetically engineered swine influenza virus and uses thereof

Chimeric viruses presenting non-native surface proteins and uses thereof

Genetically engineered swine influenza virus and uses thereof

GARCIA-SASTRE ADOLFO

Influenza virus vaccine and uses thereof

Influenza virus vaccines and uses thereof

Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof

Influenza viruses and uses thereof

(unassigned)

Recombinant negative strand RNA viruses

Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions

Genetically engineered attenuated viruses

MEDIMMUNE VACCINES INC

Recombinant negative strand RNA virus expression systems and vaccines

WORCESTER FOUND EX BIOLOGY

Inhibition of influenza virus replication by oligonucleotide phosphorothioates

AVIRON INC

Recombinant negative strand RNA virus

US HEALTH

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

MOUNT SINAI MEDICAL CENTER

Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication